journal article·2026-02Open access

Subicular Astrocytes Govern Seizure‐Impaired Fear Memory

Yuying Shao, Jing Xi, Yuhao Sun, Yulan Li, Zhisheng Li, Wangjialu Lu, Jialu Chen, Lin Yang, Fan Fei, Heming Cheng, Li Cheng, Cenglin Xu, Zhuo Huang, Vladimir Parpura, Yi Wang, Zhong Chen

Advanced Science· Volume 13· Issue 7

Abstract

Abstract The mechanisms underlying seizure‐associated cognitive impairment remain incompletely characterized. Emerging evidence positions the subiculum, a hippocampal output hub critically involved in both epileptic seizure and cognitive performance, as a putative nexus for this comorbidity. Here, it is demonstrated that astrocytic activation in the subiculum mediates seizure‐induced fear memory deficits. Subicular astrocytes dynamically respond to conditioned fear memory learning, acting as a “scavenger” for the inhibition of context memory. Seizure activity hyperactivates these leaning‐associated astrocytes and amplifies their engagement during fear processing. Suppression of subicular astrocyte Ca 2+ signaling fully rescues seizure‐induced fear memory deficits, while Gq pathway activation in the subicular astrocytes replicates cognitive impairment. Mechanistically, this seizure‐induced astrocyte dysregulation specifically involves Ca 2+ ‐dependent gliotransmitter adenosine‐mediated inhibition through A 1 receptors, reducing local neuronal excitability during fear processing. Collectively, these findings identify subicular astrocytes as critical modulators of seizure‐associated cognitive dysfunction, operating through a Ca 2+ ‐dependent adenosine‐linked pathway that disrupts neural circuit homeostasis. This work highlights the potential for astrocyte‐targeted interventions as a therapeutic strategy for seizure‐related memory disorders.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neuroscience and Neuropharmacology Research · Neuroinflammation and Neurodegeneration Mechanisms · Neurogenesis and neuroplasticity mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Medical Neurobiology of the Ministry of Health of China Institute of Pharmacology & Toxicology College of Pharmaceutical Sciences School of Medicine Zhejiang University Hangzhou 310058 China

State Key Laboratory of Natural and Biomimetic Drugs Department of Molecular and Cellular Pharmacology School of Pharmaceutical Sciences Peking University Health Science Center Beijing 100191 China

Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine Zhejiang Key Laboratory of Neuropsychopharmacology School of Pharmaceutical Sciences Zhejiang Chinese Medical University Hangzhou 310053 China

International Translational Neuroscience Research Institute School of Pharmaceutical Sciences Zhejiang Chinese Medical University Hangzhou 310053 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province

References (47)

Show source-provided references
1. 10.1111/j.1528-1167.2009.02481.x10.1111/j.1528-1167.2009.02481.x ↗
2. 10.1016/B978-0-444-52898-8.00036-710.1016/B978-0-444-52898-8.00036-7 ↗
3. 10.1016/j.tins.2004.11.01110.1016/j.tins.2004.11.011 ↗
4. 10.1038/s41582-022-00727-510.1038/s41582-022-00727-5 ↗
5. 10.1016/j.tins.2009.05.00110.1016/j.tins.2009.05.001 ↗
6. 10.1038/s41593-023-01448-810.1038/s41593-023-01448-8 ↗
7. 10.1016/S0166-2236(98)01349-610.1016/S0166-2236(98)01349-6 ↗
8. 10.1038/s41586-023-07011-610.1038/s41586-023-07011-6 ↗
9. 10.1038/s41586-024-08170-w10.1038/s41586-024-08170-w ↗
10. 10.1523/JNEUROSCI.1574-14.201510.1523/JNEUROSCI.1574-14.2015 ↗
11. 10.3389/fncel.2021.69538010.3389/fncel.2021.695380 ↗
12. 10.1016/j.pneurobio.2021.10202910.1016/j.pneurobio.2021.102029 ↗
13. 10.1126/science.107651010.1126/science.1076510 ↗
14. 10.1016/j.cell.2017.07.01310.1016/j.cell.2017.07.013 ↗
15. 10.1016/j.neuron.2017.08.01310.1016/j.neuron.2017.08.013 ↗
16. 10.1038/s41467-022-32742-x10.1038/s41467-022-32742-x ↗
17. 10.1016/j.neures.2018.08.00210.1016/j.neures.2018.08.002 ↗
18. 10.1111/j.1460-9568.1990.tb00014.x10.1111/j.1460-9568.1990.tb00014.x ↗
19. 10.1097/NEN.000000000000000210.1097/NEN.0000000000000002 ↗
20. 10.1038/s41593-018-0325-810.1038/s41593-018-0325-8 ↗
21. 10.1038/nn.420110.1038/nn.4201 ↗
22. 10.1016/S0149-7634(00)00033-610.1016/S0149-7634(00)00033-6 ↗
23. 10.1016/j.neuron.2018.08.01510.1016/j.neuron.2018.08.015 ↗
24. 10.1523/JNEUROSCI.0085-21.202110.1523/JNEUROSCI.0085-21.2021 ↗
25. 10.1007/s00429-014-0880-z10.1007/s00429-014-0880-z ↗
26. 10.1016/j.expneurol.2012.11.03110.1016/j.expneurol.2012.11.031 ↗
27. 10.1016/j.neuroscience.2014.01.04010.1016/j.neuroscience.2014.01.040 ↗
28. 10.1038/ncomms220810.1038/ncomms2208 ↗
29. 10.1016/j.neuron.2014.02.00710.1016/j.neuron.2014.02.007 ↗
30. 10.7554/eLife.3223710.7554/eLife.32237 ↗
31. 10.1016/S0301-0082(02)00155-710.1016/S0301-0082(02)00155-7 ↗
32. 10.1146/annurev.neuro.24.1.3110.1146/annurev.neuro.24.1.31 ↗
33. 10.1126/science.abb055610.1126/science.abb0556 ↗
34. 10.1126/sciadv.ads719110.1126/sciadv.ads7191 ↗
35. 10.1523/JNEUROSCI.1775-22.202310.1523/JNEUROSCI.1775-22.2023 ↗
36. 10.1038/s41467-022-34201-z10.1038/s41467-022-34201-z ↗
37. 10.3389/fncel.2020.60309510.3389/fncel.2020.603095 ↗
38. Li Y. · Elife · 2020 · 9
39. 10.1016/j.cell.2018.05.00210.1016/j.cell.2018.05.002 ↗
40. 10.1126/sciadv.adi447110.1126/sciadv.adi4471 ↗
41. 10.1038/s41593-020-0679-610.1038/s41593-020-0679-6 ↗
42. 10.1002/glia.2325010.1002/glia.23250 ↗
43. 10.1016/0168-0102(92)90040-J10.1016/0168-0102(92)90040-J ↗
44. 10.1016/j.neuropharm.2008.01.01110.1016/j.neuropharm.2008.01.011 ↗
45. 10.1016/S0169-328X(00)00194-710.1016/S0169-328X(00)00194-7 ↗
46. 10.1016/j.celrep.2023.11307310.1016/j.celrep.2023.113073 ↗
47. 10.1016/j.neuron.2024.12.00210.1016/j.neuron.2024.12.002 ↗